Angde Biotech Pharmaceutical Co., Ltd. Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2019
NCT04028518
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Angde Biotech Pharmaceutical Co., Ltd.